Overview
Scott Antonia is an Oncologist in Durham, North Carolina. Dr. Antonia is highly rated in 12 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Antonia is currently accepting new patients.
His clinical research consists of co-authoring 158 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Antonia has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
12 Clinical Trials
Duke Cancer Center
I am a medical oncologist who focuses on bone and soft tissue cancers called sarcomas. I love spending time with my patients. They often have a sense of awareness about their condition that’s truly unique and rewarding. I partner with each patient so they know the full set of options available for treatment and can make an informed decision about the approach that is best for them. I’ve wanted to pursue medicine for as long as I can remember. I find cancer fascinating because of its ability to evade the immune system. The body fails to recognize cancer as being foreign. When I am not at work, I love spending time with my family and enjoy long distance running. Dr. Riedel is highly rated in 30 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Desmoid Tumor, and Angiosarcoma.
Duke Cancer Center
I am a part of the thoracic oncology program. I work with patients who have cancers of the lung, which includes non-small cell lung cancer, small cell lung cancer, and mesothelioma. My focus is on clinical care, clinical trials, and developing new therapies for these diseases. When I first meet with a patient, I want them to understand what their diagnosis is, because there are actually multiple diagnoses of lung cancer and each are treated differently. Then I discuss with a patient whether they are a candidate for therapies such as molecular therapy or immunotherapy, and make sure they have a clear understanding of the treatment plan. There are some very promising new therapies for these diseases and we are fortunate to have those available to patients here at Duke. That’s one of the unique things we offer as an academic medical center. Dr. Stinchcombe is highly rated in 13 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Gamma Knife Radiosurgery.
Gordana Vlahovic is an Oncologist in Durham, North Carolina. Dr. Vlahovic is highly rated in 14 conditions, according to our data. Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung AdenocarcinomaDr. Antonia isElite. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Antonia isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)Dr. Antonia isElite. Learn about Small Cell Lung Cancer (SCLC).
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Antonia isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Antonia isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Antonia isDistinguished. Learn about Large-Cell Lung Carcinoma.
- MesotheliomaDr. Antonia isDistinguished. Learn about Mesothelioma.
- Pleuropulmonary BlastomaDr. Antonia isDistinguished. Learn about Pleuropulmonary Blastoma.
- Squamous Cell Lung CarcinomaDr. Antonia isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- MelanomaDr. Antonia isAdvanced. Learn about Melanoma.
- Metastatic Pleural TumorDr. Antonia isAdvanced. Learn about Metastatic Pleural Tumor.
- Experienced
- Adult Soft Tissue SarcomaDr. Antonia isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Anal CancerDr. Antonia isExperienced. Learn about Anal Cancer.
- Breast CancerDr. Antonia isExperienced. Learn about Breast Cancer.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Mantle Cell Lymphoma (MCL)Dr. Antonia isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Metastatic Brain TumorDr. Antonia isExperienced. Learn about Metastatic Brain Tumor.